Literature DB >> 18698305

Posterior cystoid retinal degeneration in central serous chorioretinopathy.

Felice Cardillo Piccolino1, Roberta Rigault De La Longrais, Marilisa Manea, Simonetta Cicinelli.   

Abstract

PURPOSE: To study the pattern of cystoid retinal changes in the posterior fundi of eyes with chronic central serous chorioretinopathy (CSC) using optical coherence tomography (OCT).
METHODS: We retrospectively studied 34 eyes with chronic CSC and cystoid retinal changes at the posterior pole documented by OCT. We analyzed the distribution of cystoid retinal changes with respect to the fovea and chorioretinal lesions.
RESULTS: Generally, cystoid retinal changes occurred in the papillomacular region (21 eyes); foveal involvement was observed in 20 eyes. Large cystoid changes in the central macula with concentric perifoveal lesion extension were detected in three eyes. Cystoid changes tended to occur where the retina adhered to subretinal fibrosis, large laser scars, or spontaneous atrophy of the retinal pigment epithelium and the choroid. Visual acuity ranged from 20/20 to 20/400. In nine eyes in which the cystoid changes spared the foveal center, visual acuity was 20/40 or better.
CONCLUSION: Cystoid retinal degeneration in eyes with chronic CSC was distributed outside of the fovea and was not necessarily associated with severely reduced visual acuity. "Posterior cystoid retinal degeneration" defines this pathologic pattern appropriately. OCT findings suggest that intraretinal exudation and cystoid changes in chronic CSC develop through the formation of chorioretinal adherences.

Entities:  

Mesh:

Year:  2008        PMID: 18698305     DOI: 10.1097/IAE.0b013e31816b4b86

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  24 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

Review 3.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

Review 4.  Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.

Authors: 
Journal:  Ophthalmologie       Date:  2022-04-06

Review 5.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

6.  Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.

Authors:  Myrte B Breukink; Susan M Downes; Giuseppe Querques; Elon H C van Dijk; Anneke I den Hollander; Rocio Blanco-Garavito; Jan E E Keunen; Eric H Souied; Robert E MacLaren; Carel B Hoyng; Sascha Fauser; Camiel J F Boon
Journal:  Trials       Date:  2015-09-21       Impact factor: 2.279

Review 7.  Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography.

Authors:  Sandeep Saxena; Khushboo Srivastav; Chui M Cheung; Joanne Yw Ng; Timothy Yy Lai
Journal:  Clin Ophthalmol       Date:  2014-12-09

8.  Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Authors:  Alejandra Daruich; Alexandre Matet; Ali Dirani; Mathilde Gallice; Luke Nicholson; Sobha Sivaprasad; Francine Behar-Cohen
Journal:  Transl Vis Sci Technol       Date:  2016-03-04       Impact factor: 3.283

9.  Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life.

Authors:  Myrte B Breukink; Alexander Jm Dingemans; Anneke I den Hollander; Jan Ee Keunen; Robert E MacLaren; Sascha Fauser; Giuseppe Querques; Carel B Hoyng; Susan M Downes; Camiel Jf Boon
Journal:  Clin Ophthalmol       Date:  2016-12-20

10.  Diagnosis and Management of a Bilateral Macular Problem.

Authors: 
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.